Obviously much of this is an insult directed at me and not based in reality, but your point on Magellan I do see as an intelligent and not often recognised point in favour of index funds
"For <10 bps with a product like the Vanguard US Total Market ETF, you're fully invested in the market, get a mix of value, growth, and defense as opposed to paying Hamish 1%+ fees with no refunds for underperformance."
This fact of an ETF as fully invested alone is what requires much higher levels of stock picking ability and market timing to maintain consistent outperformance as an active fund. Cash offers opportunity but it also requires an ability to time correctly when those opportunities are occurring and puts one at a disadvantage to an index fund, particularly after looking at fees on top of this and as you mentioned performance fees on outperformance but no refund on underperformance.
- Forums
- ASX - By Stock
- MFG
- Ann: Video update from Chief Investment Officer and Chairman
MFG
magellan financial group limited
Add to My Watchlist
0.00%
!
$8.49

Ann: Video update from Chief Investment Officer and Chairman, page-308
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$8.49 |
Change
0.000(0.00%) |
Mkt cap ! $1.461B |
Open | High | Low | Value | Volume |
$8.50 | $8.67 | $8.48 | $3.088M | 361.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1950 | $8.48 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.59 | 5048 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 10603 | 8.300 |
1 | 1175 | 8.200 |
1 | 1124 | 8.150 |
1 | 1242 | 8.050 |
3 | 4000 | 8.000 |
Price($) | Vol. | No. |
---|---|---|
8.590 | 3098 | 1 |
8.630 | 1000 | 1 |
8.650 | 3409 | 2 |
8.690 | 5000 | 2 |
8.700 | 3026 | 4 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
MFG (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online